EyeCap SL Image Capture and Management System
Navigation Links
EyeCap SL Image Capture and Management System
| Products | EyeCap SL Image Capture and Management System |
| Company | Haag-Streit USA, Inc. |
| Item | EyeCap SL Image Capture and Management System |
| Features | |
| Description | EyeCap SL is a complete image capture and management application that has been developed with cooperation from several leading ophthalmic clinicians, ophthalmic photographers and optometrists as a means to simply, accurately and securely document the eye via the slit lamp.
Images may be captured directly from slit lamps equipped with digital or video cameras as well as any other device with video or TWAIN output. The live image can be viewed on the computer screen and is then instantly stored in the database at the press of a footswitch. Segments of real time video may also be captured providing practitioners with an excellent tool for recording and monitoring of ocular pathology. EyeCap employs a unique image archiving systems that keeps acopy of all images captured on-line providing the ability to store several hundred thousand images using conventional computer hardware. This intelligent method of image storage provides clinicians with fast-track access to images from any patient visit regardless of when the original images were acquired. All images are stored in a secure environment but can be easily exported for referral or teaching and can be easily used with other applications and third party software. |
| Info | Haag-Streit USA, Inc. Customer Service: (800) 787-5426 Web site: http://haag-streit-usa.com |
Related medicine products :
1. EyeCap SL Pro Image Capture and Management System
2. EyeCap RI Image Capture and Management System
3. EyeCap FA Image Capture and Management System
4. Boss Image-Line
5. Landmarx ENT Image Guidance System
6. OmniSight Image Guided Surgery System
7. Image-Trac Posterior Spine Retractor System
8. StealthMerge Image Registration Software
9. Stealthmerge Image Registration Software
10. Imagefusion Software
11. Centricity Cardiology- Image Management and Archive
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Mini-type 1/1 (mm), opening width 4.0 mm and length 8.2 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Temporary mini-type 1/1 (mm), opening width 5.0 mm and length 6 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 10 mm.
Medicine Products:(Date:7/9/2008)...tes In-Store and Online Marketing to Create Unique...TTSBURGH and NEW YORK, July 9 /PRNewswire-FirstCal...largest global specialty retailer of,nutritional p...ource of,health information, today announced a mul... awareness and understanding of the importance of ...
(Date:7/9/2008)...y 9 /PRNewswire-FirstCall/ -- Nyer Medical Group,...DCO South Medical Supplies,Inc., ("ADCO South") i...,announced that its pharmacy division, D.A.W. Inc....ior Living, Inc. to be the preferred pharmacy,prov...cilities in,Massachusetts. The award was made at t...
(Date:7/9/2008)...RNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE:,M...o the global life,sciences markets, today announce...ed (AECL) with notice of arbitration proceedings. ...fill its contractual obligations,under its 2006 in...f not,granted, seeking significant monetary damage...
(Date:7/9/2008)... Radiotherapy Clinics of Georgia (RCOG) has beg...ing campaign. RCOG is renowned for their ProstRcis...st documented prostate cancer cure rates in the wo...B) July 9, 2008 -- Radiotherapy Clinics of Georgia...r click campaign that incorporates geo targeting f...
Breaking Medicine News(10 mins):Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:Nyer Medical Group, Inc. Announces Sale of Company's Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract 2Health News:Nyer Medical Group, Inc. Announces Sale of Company's Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Localized Online Marketing Campaign Serves to Raise Awareness of Prostate Cancer Treatment 2Health News:Localized Online Marketing Campaign Serves to Raise Awareness of Prostate Cancer Treatment 3[0] GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle[0] Nyer Medical Group, Inc. Announces Sale of Company's Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract[0] MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada[0] Localized Online Marketing Campaign Serves to Raise Awareness of Prostate Cancer Treatment
...ue to changes in the tissue environment of the bre...er by McDaniel. This study has found a place in th...ogy. // The stages of pregnancy, lactation, and i... the tissues of the human breast, resulting in mul...
...improper usage of MP3 and iPods, like listening to...ecting the hearing capabilities of a person. // Th...aul R. Kileny revealed that such devices are not i...if not used in the proper manner. Most people find...
...e unlucky for Biomedical Tissue Services Ltd a com...on from cadavers. // The Food and Drug Administr...aws in the donor policies that might pose a threat... to disease. Though, none of the patients have bee...
...n University have revealed that the ageing of the ...ls. // This conclusion has been arrived at after s...in it was found that as the animals grow older, th... the ageing cells in their skin. The idea that c...
Other Medicine News:Health News:Chicago :FDA imposes Ban on Biomedical Tissue Services 2(Date:7/7/2008)...e/ -- OrbusNeich today announced that data,present...nese Society of,Interventional Cardiology demonstr...ter outcomes when compared to drug-eluting stents....,s principal,investigator and a professor with the...rdiology, Department of Clinical Medicine and Card...
(Date:7/7/2008)...fruit is Top Performer in the Body, SEATTLE, July...l when,it comes to their antioxidant powers in the...bility compared to other antioxidant-rich fruits a... in the Journal of the,American College of Nutriti...cals called flavonoids that,may have the power to ...
(Date:7/3/2008)...swire-FirstCall/ -- Medivation, Inc.,(Nasdaq: MDV...ence at 5:00,p.m. EDT on Monday, July 7, to discus...nd, placebo-controlled Phase 2 clinical trial of,d...ce/Webcast Details, To participate in the live ca... telephone, please dial 877-419-6590 from the U.S....
(Date:7/3/2008)...BRIDGE Massachusetts, July 3,/PRNewswire-FirstCall...logy company, Jerini AG for an equity purchase pr... (HAE) product, FIRAZYR(R), to its Human Genetic ...global sales expected to be around $350-400 milli...e environment, - Expected to be accretive for Non...
Breaking Medicine Technology:Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Kiwifruit: Antioxidant Power in Quantity and Quality 2Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Complementary Excerpt Available from Best Practices 3A Resources Structure and Processes to Optimize Pharmaceutical Sales Communications 17241 1Complementary Excerpt Available from Best Practices 3A Resources Structure and Processes to Optimize Pharmaceutical Sales Communications 17241 2Gene Therapy in Rats Reduces Cocaine Use 17237 1Gene Therapy in Rats Reduces Cocaine Use 17237 2Dealing Cervical Cancer a Knockout Blow 17234 1Dealing Cervical Cancer a Knockout Blow 17234 2Dealing Cervical Cancer a Knockout Blow 17234 3Best Practice Database 3A Valuable Strategies for Pharmaceutical Product Launches 17230 1Best Practice Database 3A Valuable Strategies for Pharmaceutical Product Launches 17230 2[0] Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents[0] Kiwifruit: Antioxidant Power in Quantity and Quality[1] Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease[0] Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
...HICAGO, June 21, 2007 /PRNewswire-FirstCall/ -- Ad...ced positive results from,Trial CL-06, the first o...assess the safety and effectiveness of cethromycin... of community,acquired pneumonia (CAP). In the stu...imary endpoint of per protocol clinical,cure rate ...
...ummary: Pharmexa-Epimmune, the U.S.-based subsidia...s influenza vaccine,program today at the Influenza...Influenza VI," held in Toronto, Ontario, Canada. T...o induce,cell-mediated immune responses can protec...uenza virus challenge. , HORSOLM, Denmark, June 21...
Other Medicine Technology:Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 2Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 3Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 4Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 5Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |